Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Change in Cash (2016 - 2026)

Champions Oncology has reported Change in Cash over the past 17 years, most recently at -$1.4 million for Q1 2026.

  • Quarterly results put Change in Cash at -$1.4 million for Q1 2026, down 410.04% from a year ago — trailing twelve months through Jan 2026 was $3.9 million (up 410.03% YoY), and the annual figure for FY2025 was $7.2 million, up 195.56%.
  • Change in Cash for Q1 2026 was -$1.4 million at Champions Oncology, up from -$1.8 million in the prior quarter.
  • Over the last five years, Change in Cash for CSBR hit a ceiling of $6.6 million in Q2 2025 and a floor of -$5.2 million in Q3 2023.
  • Median Change in Cash over the past 5 years was $274000.0 (2024), compared with a mean of $138000.0.
  • Peak annual rise in Change in Cash hit 455.84% in 2025, while the deepest fall reached 1210.87% in 2025.
  • Champions Oncology's Change in Cash stood at $2.8 million in 2022, then plummeted by 76.73% to $644000.0 in 2023, then tumbled by 121.43% to -$138000.0 in 2024, then tumbled by 1210.87% to -$1.8 million in 2025, then grew by 23.22% to -$1.4 million in 2026.
  • The last three reported values for Change in Cash were -$1.4 million (Q1 2026), -$1.8 million (Q4 2025), and $540000.0 (Q3 2025) per Business Quant data.